New drug delivery systems and innovative processesAt Ellipse Pharmaceuticals, 25% of the R&D activity is aiming to develop specific know-how and proprietary formulation concepts. Since 1999, various patents regarding new DDS (Drug Delivery Systems) and new pharmaceutical processes have been filed. These specific know-how and technologies are available for licensing.
|
Modified release tablets (delayed, sustained, bimodal, gastro-resistant)
|
|
|
Multiple unit formulations(microgranules, multiple layer-tablets, pellets…)
|
|
|
Gastro-resident formulations
|
|
|
Emulsions / Micro-emulsions
|
|
|
Freeze-dried formulations
|
|
|
Smart gels for mucosal applications
|
For more details, please contact
Mrs Frédérique Bordes Picard.
